Postpone the SSC Decision For Two Years

There are several arguments against the Superconducting Supercollider that come from outside high-energy physics. High-energy physics, an exciting pioneer field in science, suffers from Big Science syndrome: it requires massive efforts in human and material resources to further the acquisition of knowledge. Meanwhile, areas systemic research show great promise with only moderate expenditure of resources. Huge potential breakthroughs in the principles of accelerator building (such as the superc

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

There are also arguments internal to high-energy physics. In the last 50 years a series of ever-costlier accelerators have been built, each demanded by the theoretical high-energy physicists as indispensable for finding the solution to the central "strong interaction" problem. The new accelerators caused the older ones to be shut down for lack of funds even though the latter could still have been used to do interesting research. Thus, each machine was very much underutilized.

Yet today, after a sequence of unsuccessful theoretical attempts, we still do not understand strong interactions. Hardly 10 percent of the data accumulated by past accelerators can be explained (even to an accuracy of 10 percent) by existing theories. Even worse, the latest theories claim that most of these data were taken in the wrong range of parameters, and, hence, new data from new accelerators are needed to make progress.

On the basis of this ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Michael Moravcsik

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide